EBM Consult Focused Topic

EBM Consult Focused Topic

Copyright EBM Consult, LLC.

NOTE:

Dear Author,

Please fill each section and row of every table where applicable. If no data exist, please designate that none exists or leave blank.

For a sample EBM Article to serve as an example or model go to: https://www.ebmconsult.com/articles/hints-head-impulse-exam-diagnosis-central-causes-dizziness

ARTICLE TITLE:

Fill is your PICOTS: P stands for patient, I stands for intervention or treatment, C stands for comparison, O stands for outcome, T stands for the time frame for assessing the outcome…and S stands for the setting of the questions being asked.

P =

I =

C =

O =

T =

S =

Take Home Point(s):

§ Take home point #1

§ Take home point #2

§ Take home point #3

§ Take home point #4

Summary:

[Note: This where the concise summary or answer or explanation should go. This should be < ½ a page. It is also the place to make the evidence come alive and clinically relevant /useful to people. Feel free to add clinical pearls or things that are practical to working clinicians. This area is NOT meant to be an exhaustive summary of every study. It can summarize the totality of the data below in tables but not a study-by-study breakdown – no one wants to read all of that].

Author(s):
Editor(s):

Reviewers: Note: you must have 1 peer reviewer review before submitting along with that reviewer’s name and contact info

Date Last Reviewed: X

Supporting Guideline Statements:
Organization Name & Date:
“Insert rec here.”
Guideline Rating: X
Reference:
[EXAMPLE FORMAT: Lip GY et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014;35(45):3155-79. PMID: 25154388]
Organization Name & Date:
“Insert rec here.”
Guideline Rating: X
Reference:
Author etc …. PMID: ####
Organization Name & Date:
“Insert rec here.”
Guideline Rating: X
Reference:
Author etc …. PMID: ####
Organization Name & Date:
“Insert rec here.”
Guideline Rating: X
Reference:
Author etc …. PMID: ####
Organization Name & Date:
“Insert rec here.”
Guideline Rating: X
Reference:
Author etc …. PMID: ####

Note: Provide the direct quotation of their statement here; also include class or level of evidence if provided and citation and PMID#

Notes: DO NOT use bullets or insert tables within any of the rows or columns – ONLY single line text. If a row is not applicable or info is not available from paper then leave it blank or empty.

META-ANALYSIS or COCHRANE REVIEWS:
Reference: [Insert here]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria:
Exclusion Criteria:
Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
*Add more here if needed
ORIGINAL & SUPPORTING CLINICAL TRIALS (RCTs or other Prospective Studies)
Reference: [Insert here]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria:
Exclusion Criteria:
Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
*Add more here if needed
COHORT STUDIES, CASE SERIES or CASE REPORTS:
Reference: [Insert here]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria:
Exclusion Criteria:
Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
Reference: AUTHOR etc… [link]http://www.ncbi.nlm.nih.gov/pubmed/?term=21621092|PubMed[/link]
Level of Evidence: / http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pdf
PICOTS / Insert PICOTS for this paper only
Study Design:
Sample Size:
Population:
Inclusion Criteria
Exclusion Criteria
Groups & Interventions:
Other Treatments:
Follow-up or Duration:
Primary Endpoint (Purpose):
Secondary Endpoint(s):
Results:
Prevalence:
NNT/NNH:
Conclusions:
Location(s):
Funding:
ClinicalTrials.gov
Comment(s):
*Add more here if needed
Related Article & Reviews:
Reference: see sample for format; include PMID
Reference: see sample for format; include PMID

Expert Comments:

Note: you can put something here but the editorial staff will decide if it is used in final document

Author(s):

First and Last Name +

Title or Position +

Institution or Practice Site

Department

City, State

Reviewer(s) That Reviewed PRIOR to Submission: